FDA approves new drug to treat schizophrenia, MDD

E-ISSN： 1556-7583|25|28|6-6

ISSN： 1058-1103

Source： MENTAL HEALTH WEEKLY, Vol.25, Iss.28, 2015-07, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

FDA approves new drug to treat schizophrenia, bipolar disorder

MENTAL HEALTH WEEKLY, Vol. 25, Iss. 37, 2015-09 ,pp. : 6-7

John Wiley & Sons Inc

Access to resources Recommend Favorite

FDA approves Rexulti to treat schizophrenia and as an add‐on to an antidepressant to treat major depressive disorder

THE BROWN UNIVERSITY CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY UPDATE, Vol. 17, Iss. 9, 2015-09 ,pp. : 8-8

John Wiley & Sons Inc

Access to resources Recommend Favorite

FDA approves first generic Abilify to treat mental illnesses

MENTAL HEALTH WEEKLY, Vol. 25, Iss. 18, 2015-05 ,pp. : 6-7

John Wiley & Sons Inc

Access to resources Recommend Favorite

FDA approves new indication — opioid withdrawal — for electric stimulation device

THE BROWN UNIVERSITY CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY UPDATE, Vol. 20, Iss. 1, 2018-01 ,pp. : 8-8

John Wiley & Sons Inc

Access to resources Recommend Favorite

FDA approves revised prescribing for clozapine; new REMS in effect

THE BROWN UNIVERSITY PSYCHOPHARMACOLOGY UPDATE, Vol. 26, Iss. 12, 2015-12 ,pp. : 1-5

John Wiley & Sons Inc

Access to resources Recommend Favorite